(Q39640248)

13 September 2017

title

Predictive biomarkers in the management of EGFR mutant lung cancer (English)

1 reference

13 September 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20973798

9 August 2024

1

Rafael Rosell

1 reference

13 September 2017

5

Santiago Viteri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20973798

9 August 2024

author name string

Teresa Moran

2

1 reference

13 September 2017

Felipe Cardenal

3

1 reference

13 September 2017

Rut Porta

4

1 reference

13 September 2017

Miguel Angel Molina

6

1 reference

13 September 2017

Susana Benlloch

7

1 reference

13 September 2017

Miquel Taron

8

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.2010.05775.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

https://nyaspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1749-6632.2010.05775.x

9 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Annals of the New York Academy of Sciences

9 August 2024

published in

1 reference

13 September 2017

volume

1210

1 reference

13 September 2017

page(s)

45-52

1 reference

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

13 September 2017

cites work

1 reference

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.0905234106

Personalized medicine and inhibition of EGFR signaling in lung cancer

1

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

9 August 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

9 August 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations

9 August 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib

9 August 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

9 August 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

9 August 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Screening for epidermal growth factor receptor mutations in lung cancer

9 August 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

9 August 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer

9 August 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer

9 August 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.

9 August 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

9 August 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Detection of mutations in EGFR in circulating lung-cancer cells

9 August 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

9 August 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

9 August 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

9 August 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

9 August 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

9 August 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

9 August 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

9 August 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

9 August 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells

9 August 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.

9 August 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation.

9 August 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer

9 August 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis

9 August 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile

9 August 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer

9 August 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

9 August 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients

9 August 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.2010.05775.X

9 August 2024

Identifiers

1 reference

13 September 2017

1 reference